• June 3-6, 2024
  • San Diego Convention Center, California


Tari Suprapto

Tari Suprapto, PhD

Director, Search & Evaluation (Western US & Canada)
Novo Nordisk
Tari Suprapto, Ph.D., RTTP is a seasoned technology commercialization professional in the life sciences. She is currently the Director for Search & Evaluation for Western US and Canada for Novo Nordisk, and previously was part of the External Innovation team at Elanco. Tari spent over 15 years commercializing innovations from world-class research institutions such as the Salk Institute, The Rockefeller University, and Memorial Sloan-Kettering Cancer Center. Tari has extensive experience in licensing, building and managing strategic alliances, and a strong scientific background in a variety of therapeutic areas evidenced by her Ph.D. in cell biology from The Rockefeller University and an Honors B.A. from Swarthmore College. Tari is also a member of BIOCOM’s Capital Development Committee and is official advisor to Founders Corner Venture Capital and CEO 360 in San Diego. Most recent previous speaking engagements: “Conversations with Corporate Colleagues” at BIO on the Bayou, Oct 3, 2023 and “Biotech Building and Scaling Under Current Macroenvironment” at SoCal Association for Biomedical and Pharmaceutical Advancements (SABPA), Sept 30, 2023. Also “Demystifying Partnering With Pharma” for BIOCOM’s Global Life Sciences Partnering Conference Feb 2023.
Speaking In


Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.